Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Streptococcus infantis X strain:X

ABSTRACT: Reference genome for Human Microbiome Project

PROVIDER: PRJNA64693 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	AFUQ01.dat.gz	Other
	AFUQ01.fasta.gz	Fasta.gz
	AFUQ01.master.dat	Other
	SRR173059.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Streptococcus infantis SK970

Project description:Reference genome for Human Microbiome Project

| PRJNA67191 | ENA

Streptococcus infantis SK1076

Project description:Reference genome for Human Microbiome Project

| PRJNA65583 | ENA

Streptococcus infantis ATCC 700779

Project description:Reference genome for Human Microbiome Project

| PRJNA158721 | ENA

Streptococcus infantis ATCC 700779

Project description:Reference genome for the Human Microbiome Project

| PRJNA53205 | ENA

Bifidobacterium longum subsp. infantis CCUG 52486

Project description:Reference genome for the Human Microbiome Project

| PRJNA30065 | ENA

Bifidobacterium longum subsp. infantis (B. infantis) strain dependent utilization of human milk oligosaccharides

Project description:Bifidobacterium longum subsp. infantis (B. infantis) colonizes the infant gut microbiome with a 43-kb gene cluster that enables human milk oligosaccharide (HMO) utilization. Although there is relative genomic homogeneity in this regard, previous observations suggest that B. infantis strains may differ in their utilization phenotype. To test this hypothesis, a panel of B. infantis strains were evaluated for their ability to utilize pooled HMOs to yield differential phenotypes including biomass accumulation, HMO consumption glycoprofile, end-product secretion, and global transcriptomes. Two strains (ATCC 15697 and UMA301) efficiently consumed several HMO isomers/anomers that exhibit degrees of polymerization (DP) ³ 4. These same strains partially consumed the smaller DP HMOs including fucosyllactose and lactodifucotetraose isomers/anomers. In contrast, UMA299 efficiently utilized fucosylated small molecular weight HMOs (DP<4), and accumulated greater biomass on purified 2´FL with significantly higher 1,2-propanediol production. This study identifies several strain-dependent features in HMO utilization phenotypes that are consistent with metabolic variation within a bifidobacterial-dominated infant-gut microbiome.

2020-12-30 | GSE164005 | GEO

Streptococcus oralis SK313

Project description:Reference genome for Human Microbiome Project

| PRJNA67193 | ENA

Streptococcus sp. OBRC6

Project description:Human Microbiome Project (HMP) Reference Genome

| PRJNA165931 | ENA

Streptococcus sp. BS29a

Project description:Human Microbiome Project (HMP) Reference Genome

| PRJNA165933 | ENA

Streptococcus sp. AS20

Project description:Human Microbiome Project (HMP) Reference Genome